Tainted ED
This article was originally published in The Tan Sheet
Executive Summary
New York-based EG Labs voluntarily recalls all lots of its Viapro 375mg capsules after FDA found an undisclosed ingredient - thiomethisosildenafil, an analog of an active ingredient in prescription erectile dysfunction drugs. The capsules were sold by retailers nationwide and were packaged in one- and two-count blister packs and 10-count bottles. The product has not been sold since March 2008, the firm says. In another recent case, FDA seized $74,000 in mislabeled erectile dysfunction supplements from SEI Pharmaceuticals (1"The Tan Sheet" July 28, 2008, p. 15)...
You may also be interested in...
FDA Maintains Pressure Against Adulterated ED Supplements
FDA says its seizure of $74,000 in mislabeled erectile dysfunction supplements from SEI Pharmaceuticals July 24 demonstrates the steps the agency will take when a company fails to heed a warning about an allegedly adulterated product
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.